GMT Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

GMT Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-32,690	Closed	-$1.94M	–	138
2016 Q4	$1.94M	Sell	32,690 -345,060	-91%	-$21.3M	0.04%	108
2016 Q3	$25M	Sell	377,750 -8,350	-2%	-$517K	0.51%	61
2016 Q2	$20.9M	Buy	386,100 +53,700	+16%	+$2.94M	0.51%	51
2016 Q1	$17.2M	Buy	+332,400	New	+$17.3M	0.42%	57

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

GMT Capital's XBI Position: Q1 2017 in Review

GMT Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2017, closing a stake of 32,690 shares — an estimated $1.94M sold.

GMT Capital first reported a position in XBI in Q1 2016 and held it in 4 quarters. The position peaked at $25M in Q3 2016. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

GMT Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2017 after selling out during the quarter.
GMT Capital sold 32,690 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $1.94M.
GMT Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and held it in 4 quarters.
GMT Capital's State Street SPDR S&P Biotech ETF position peaked at $25M in Q3 2016.
292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on GMT Capital's 13F filing for Q1 2017, filed 12 May 2017.